This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Unveiling the Innovations of Xiaojie (Jeff) Zhu in Andover, MA
Introduction:
Xiaojie (Jeff) Zhu, a talented inventor based in Andover, MA, has made significant contributions to the field of pharmaceuticals and cancer treatment. With a total of 2 patents under his name, his groundbreaking work has been recognized for its innovative approaches.
Latest Patents:
1. Intermediates and methods for making zearalenone macrolide analogs: Zhu's patented method and intermediates pave the way for the synthesis of macrolides, specifically compounds of formula (IV), showing potential in the pharmaceutical industry.
2. Luminacin analogs and uses thereof: His second patent focuses on compounds with formula (I) for cancer treatment, demonstrating his versatility in developing novel therapies.
Career Highlights:
Xiaojie (Jeff) Zhu is currently part of the Eisai R&D Management Co., Ltd., where he continues to push boundaries in drug discovery and development. His expertise and dedication have led to valuable advancements in the pharmaceutical sector.
Collaborations:
Working alongside esteemed colleagues such as Roch Boivin and Silvio A. Campagna, Zhu thrives in an environment that fosters collaboration and collective innovation. Together, they form a formidable team driving towards excellence.
Conclusion:
In conclusion, Xiaojie (Jeff) Zhu's inventive spirit and relentless pursuit of novel solutions have established him as a prominent figure in the world of pharmaceutical research. His patents stand as a testament to his ingenuity and commitment to advancing healthcare through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
